Serum levels of tissue polypeptide specific antigen are correlated with hepatocyte cytokeratin expression in alcoholic liver disease

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 9, 2004, Pages 1413-1418

  Gonzalez Quintela, A ^a,b   Mella, C ^a   Abdulkader, I ^a   Perez, L F ^a   Campos, J ^a   Otero, E ^a   Forteza, J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 8; MONOCLONAL ANTIBODY; TISSUE POLYPEPTIDE ANTIGEN;

ADULT; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; FEMALE; HEPATOCYTES; HUMANS; KERATINS; LINEAR MODELS; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; PEPTIDES; STATISTICS, NONPARAMETRIC;

EID: 4544361832     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000139824.23340.74     Document Type: Article

References (36)

1. Baptista A, Bianchi L, de Groote J, Desmet VJ, Gedigk P, Korb G, McSween RNM, Popper H, Poulsen H, Scheuer PJ, Schmidt M, Thaler H, Wepler W (1981) Alcoholic liver disease; morphological manifestations. Review by an international group. Lancet 1:707-711.
2. Berglund A, Molin D, Larsson A, Einarsson R, Glimelius B (2002) Tumour markers as early predictors of response to chemotherapy in advanced colorectal carcinoma. Ann Oncol 13:1430-1437.
3. Bonfrer JM, Groeneveld EM, Korse CM, Van Dalen A, Oomen LC, Ivanyi D (1994) Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18. Tumor Biol 15:210-222.
4. Buccheri G, Ferrigno D (2001) Lung tumor markers of cytokeratin origin: an overview. Lung Cancer 34 (Suppl 2):S65-S69.
5. Burt AD, Steward JA, Aitchison M, McSween RNM (1987) Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease. J Clin Pathol 40:719-724.
6. Caulin C, Salvesen GS, Oshima RG (1997) Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 138:1379-1394.
7. Collazos J, Genollá J, Ruibal A (1993) A clinical and biochemical study on tissue polypeptide antigen (TPA) in non-malignant hepatic disorders. Scand J Clin Lab Invest 53:633-637.
8. Denk H, Krepier R, Lackinger E, Artlieb U, Franke WW (1982) Immunological and biochemical characterization of the keratin-related component of Mallory bodies: a pathological pattern of hepatocytic cytokeratins. Liver 2:165-175.
9. Gallo V, Cerrutti E, Riberi A, Re M, Petrino R, Pecchio F (1989) Alpha-fetoprotein and tissue polypeptide antigen in non neoplastic hepatic disorders. J Nucl Med Allied Sci 33 (3 Suppl):89-93.
10. Gonzalez-Quintela A, Mella C, Perez LF, Abdulkader I, Caparrini AM, Lojo S (2000) Increased serum TPS (tissue polypeptide specific antigen) in alcoholics. A possible marker of alcoholic hepatitis. Alcohol Clin Exp Res 24:1222-1226.
11. Ishii H, Adachi M, Fernandez-Checa JC, Cederbaum AI, Deaciuc IV, Nanji AA (2003) Role of apoptosis in alcoholic liver injury. Alcohol Clin Exp Res 27:1207-1212.
12. Jensen K, Gluud C (1994) The Mallory body: morphological, clinical and experimental studies (part 1 of a literature survey). Hepatology 20:1061-1077.
13. Kachi K, Cadrin M, French SW (1993) Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. An electron microscopic autoradiography assay. Lab Invest 68:71-81.
14. Kawahara H, Matsuda Y, Takase S (1994) Is apoptosis involved in alcoholic hepatitis? Alcohol Alcohol 29 (Suppl 1):113-118.
15. Leandro G, Zizzari S, Piccoli A, Manghisi OG (1990) The serum tissue polypeptide antigen in the detection of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 37:449-451.
16. Mallory FB (1911) Cirrhosis of the liver: five different lesions from which it may arise. Bull Johns Hopkins Hosp 22:69-75.
17. Moraglio D, Pagano M, Galeazzi D, Arnelli A, Bertero L (1994) Tissue polypeptide specific antigen (TPS) in liver disease. Clin Chim Acta 224:209-214.
18. Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M, Laufer D (1999) Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 85:1018-1025.
19. Omary MB, Ku NO, Toivola DM (2002) Keratins: guardians of the liver. Hepatology 35:251-257.
20. Plebani M, Basso D, Del Favero G, Ferrara C, Meggiato T, Fogar P, Mangano F, Ricciardi G, Burlina A (1993) Clinical utility of TPS, TPA and CA 19-9 measurement in pancreatic cancer. Oncology 50:436-440.
21. Putzki H, Ledwoch J, Student A, Jablonski M, Heymann H (1988) Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases. J Surg Oncol 37:133-135.
22. Rydlander L, Ziegler E, Bergman T, Schoberl E, Steiner G, Bergman AC, Zetterberg A, Marberger M, Bjorklund P, Skern T, Einarsson R, Jornvall H (1996) Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem 241:309-314.
23. Sabbatani S, Monti M, Fini A (1988) Tissue polypeptide antigen (TPA) modifications in hepatic cirrhosis, aggressive chronic active hepatitis, persistent chronic hepatitis, and in minimal pathology. Int J Biol Markers 3:127-128.
24. Savolainen VT, Lalu K, Penttila A, Virtanen I, Karhunen PJ (1994) Cytokeratin inclusions in alcoholic liver disease and their relation to the amount of alcohol intake. Liver 14:281-287.
25. Schirmacher P, Dienes HP, Moll R (1998) De novo expression of non-hepatocellular cytokeratins in Mallory body formation. Virchows Arch 432:143-152.
26. Sheard MA, Vojtesek B, Simickova M, Valik D (2002) Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis. J Cell Biochem 85:670-677.
27. Stumptner C, Omary MB, Fickert P, Denk H, Zatloukal K (2000) Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a Mallory body mouse model. Am J Pathol 156:77-90.
28. Suzuki S, Furukawa H, Tsuchiya A (1999) Clinical evaluation of serum tissue polypeptide specific antigen in patients with thyroid carcinoma. Thyroid 9:921-925.
29. Takahashi T, So-Wan T, Kamimura T, Asakura H (2000) Infiltrating polymorphonuclear leukocytes and apoptotic bodies derived from hepatocytes but not from ballooning hepatocytes containing Mallory bodies show nuclear DNA fragmentation in alcoholic hepatitis. Alcohol Clin Exp Res 24 (4 Suppl):68S-73S.
30. Van Dalen A (1999) TPS monitoring in metastatic breast cancer. Int Biol Markers 14:45-48.
31. Van Eyken P (2000) Cytokeratin immunohistochemistry in liver histopathology. Adv Clin Pathol 4:177-251.
32. Van Eyken P, Desmet VJ (1993) Cytokeratins and the liver. Liver 13:113-122.
33. Van Eyken P, Sciot R, Desmet VJ (1988) A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express "bile duct-type" cytokeratins. Histopathology 13:605-617.
34. Vyberg M, Leth P (1991) Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease. APMIS 23 (Suppl):46-52.
35. Zatloukal K, Bock G, Rainer I, Denk H, Weber K (1991) High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter. Lab Invest 64:200-206.
36. Yao WJ, Wang ST, Chow NH, Chang TT, Lin PW, Tu DG (2002) Serum tissue polypeptide specific antigen as noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection. Cancer 95:112-118.